Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-12

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Post Market Clinical Follow-Up of Plasmafit® Cup

NCT02019849

Total Hip Arthroplasty

COMPLETED

Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants

NCT06626490

Revision Total Hip Arthroplasty Periprosthetic Fracture of Hip

NOT_YET_RECRUITING

Cemented TrendHip® - Multicenter PMCF Study on Total Indications

NCT04943328

Coxarthrosis; Primary Coxarthrosis; Post-Traumatic Necrosis, Femur Head +3 more

ACTIVE_NOT_RECRUITING NA

Benefit of Orthopedic Navigation in the ARThroplasty of the Hip

NCT01496300

Osteoarthritis, Hip Arthritis, Rheumatoid Femur Head Necrosis

COMPLETED PHASE4

Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction

NCT03382665

Osteoarthritis Avascular Necrosis Rheumatoid Arthritis +10 more

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteolysis Arthroplasty Complications Instability of Prosthetic Joint Degenerative Osteoarthritis Rheumatic Arthritis Fractures, Hip Femoral Head Avascular Necrosis Prosthesis Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Plasmafit® Revision Structan®

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Plasmafit® Revision Structan®

Intervention Type DEVICE

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plasmafit® Revision Structan®

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for the cementless Plasmafit® Revision Structan® Hip Endoprosthesis Cup (primary and revision cases, with bone conditions typically demanding a press-fit revision cup)
* Written informed consent
* Cases where a press-fit cup fixation is possible

Exclusion Criteria

* Patients \< 18 years
* Pregnant patients
* Patients not able to comply with the study demands, i.e. follow-up visits (mentally or physically)
* Patient has an infection in the hip joint region

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No